Ruth Frances Keir runs Cam­bridge Cog­ni­tion (AIM: COG), one of the 10 Com­pa­nies to Watch in 2013/ 2014 accord­ing to our lat­est mar­ket report, which devel­ops and com­mer­cial­izes com­put­erised neu­ropsy­cho­log­i­cal tests used in a vari­ety of health­care and research set­tings. She joined the Cam­bridge Cog­ni­tion board ini­tial­ly in 2010 as a non-exec­u­tive direc­tor, bring­ing to it more than 26 years’ expe­ri­ence in research and busi­ness devel­op­ment posi­tions in the phar­ma­ceu­ti­cal indus­try, as well as a peri­od as Direc­tor of her own con­sul­tan­cy busi­ness, Archea Ltd.

–> To Learn More and Reg­is­ter, click on 2013 Sharp­Brains Vir­tual Sum­mit: Sep­tem­ber 19–20th, 2013